GE HealthCare Technologies Inc. (GEHC) Income Statement
An income statement shows a company's revenue, expenses, and profit over a reporting period.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally.
Total Revenue Chart for GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. (GEHC) revenue for FY2025 was USD 20.6B, a 4.8% change from FY2024. GE HealthCare Technologies Inc.'s revenue grew from USD 16.6B in 2019 to USD 20.6B in 2025 (24.0% over 6 years). Earnings per share grew from USD 3.35 in 2019 to USD 4.22 in 2022 (25.9%). Revenue compound annual growth rate: 5-year CAGR of 3.7%.
Total Revenue (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $31.98B
- Implied Share Price
- $70.31
- Enterprise Value
- $39.19B
- Revenue (TTM)
- $21.27B
- EBITDA
- $3.59B
- Profit Margin
- 9.33%
- Trailing P/E
- 16.16
- Forward P/E
- 13.83
- Price/Book (MRQ)
- 2.80
- Price/Sales (TTM)
- 1.50
- EV/EBITDA
- 10.61
- EV/Revenue
- 1.84
- Dividend Yield
- 0.20%
- Book Value
- $24.30
- Free Cash Flow (FY2025)
- $1.51B
- Free Cash Flow Yield
- 4.71%
Snapshot as of 6th August 2026 — not point-in-time controlled, may lag the live market by a few days.